InjectionClinical Overview
Meropenem and Sulbactam is a potent ultra-broad-spectrum parenteral carbapenem-beta-lactamase inhibitor combination. Meropenem resists degradation by renal dehydropeptidase-1 and binds penicillin-binding proteins with high affinity, while sulbactam neutralizes beta-lactamases and exerts direct bactericidal activity against Acinetobacter baumannii. Indicated for life-threatening nosocomial infections, ventilator-associated pneumonia, septicemia, complicated intra-abdominal infections, and severe surgical sepsis caused by MDR pathogens.
Active Pharmaceutical Ingredients
Verified Clinical References
Usage Guidelines
Administered strictly in hospital and intensive care units via slow intravenous infusion over 30 to 60 minutes (or extended infusion over 3-4 hours) after reconstitution with Water for Injections or Normal Saline. Dose must be individualized by an infectious disease specialist.
General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.
Possible Side Effects
Common: Diarrhea, nausea, vomiting, headache, rash, injection site phlebitis, thrombocytosis. Rare/Severe: Seizures/neurotoxicity (especially in renal impairment), severe anaphylaxis, Clostridioides difficile colitis, and agranulocytosis.
*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.
Precautions & Warnings
Contraindicated in patients with severe hypersensitivity to carbapenems or beta-lactams. Use with caution in patients with CNS disorders, epilepsy, or renal insufficiency; dosage must be adjusted strictly according to creatinine clearance. Co-administration with valproic acid reduces valproate levels, precipitating breakthrough seizures.
Schedule H1 (Prescription Required)
This medication is scheduled under statutory drug regulatory frameworks (CDSCO / Drugs & Cosmetics Rules). Dispensing requires a valid medical prescription from a registered medical practitioner. Self-medication or unsupervised dosage adjustment carries significant clinical risks.
Medical Disclaimer: Statutory Clinical Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice, clinical diagnosis, or treatment recommendations. Always consult a registered medical practitioner or qualified pharmacist before initiating, modifying, or substituting any medication regimen.
Cefoperazone 1g + Sulbactam 1g Injection
Cefoperazone Sodium and Sulbactam Sodium is a high-potency parenteral combination targeting resistant Gram-negative bacilli and anaerobes. Cefoperazone offers broad anti-pseudomonal and Gram-negative bactericidal coverage excreted primarily via the biliary route, while sulbactam inhibits beta-lactamases and possesses intrinsic activity against Acinetobacter baumannii. Indicated for intra-abdominal infections, biliary tract sepsis, hospital-acquired pneumonia, gynecological infections, and polymicrobial bacteremia.
Cefoperazone 500mg + Sulbactam 500mg Injection
Cefoperazone Sodium and Sulbactam Sodium is a high-potency parenteral combination targeting resistant Gram-negative bacilli and anaerobes. Cefoperazone offers broad anti-pseudomonal and Gram-negative bactericidal coverage excreted primarily via the biliary route, while sulbactam inhibits beta-lactamases and possesses intrinsic activity against Acinetobacter baumannii. Indicated for intra-abdominal infections, biliary tract sepsis, hospital-acquired pneumonia, gynecological infections, and polymicrobial bacteremia.
Cefotaxime Sodium 1g + Sulbactam Sodium 500mg Injection
Cefotaxime Sodium and Sulbactam Sodium is a parenteral combination of a third-generation cephalosporin and a beta-lactamase inhibitor. Cefotaxime inhibits bacterial cell wall synthesis with exceptional activity against Gram-negative bacilli and Streptococcus pneumoniae, while sulbactam neutralizes beta-lactamases produced by resistant pathogens. Indicated for severe intra-abdominal infections, septicemia, meningitis, hospital-acquired pneumonia, and bone and joint infections.
Cefotaxime Sodium 250mg + Sulbactam Sodium 125mg Injection
Cefotaxime Sodium and Sulbactam Sodium is a parenteral combination of a third-generation cephalosporin and a beta-lactamase inhibitor. Cefotaxime inhibits bacterial cell wall synthesis with exceptional activity against Gram-negative bacilli and Streptococcus pneumoniae, while sulbactam neutralizes beta-lactamases produced by resistant pathogens. Indicated for severe intra-abdominal infections, septicemia, meningitis, hospital-acquired pneumonia, and bone and joint infections.